Most if not all therapeutic targets are glycosylated proteins. The role of glycosylation has largely been ignored due to the complexity of the science and the lack of available tools to mine novel drug targets. Our platform uniquely allows you to characterize your novel targets’ glycosylation isoforms and their respective role as highly specific drug targets.
You are developing a new molecule that is targeting a glycosylated protein
You need to understand the pathomechanistic role of different glycosylated isoforms of your target
You need to understand if your molecule interacts differently with different glyco-isoforms of your target
You are looking for a liquid-biopsy-based surrogate assay to stratify patients for your glycoprotein-targeting new therapy
